{"id":"W4394981645","doi":"10.1016/j.eclinm.2024.102604","title":"Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update","year":2024,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Hospital for Sick Children; Pediatric Oncology Group","funders":"Canadian Institutes of Health Research; U.S. Food and Drug Administration; National Institutes of Health; Pediatric Oncology Group of Ontario; Abramson Cancer Center; Centers for Disease Control and Prevention; Canada Research Chairs; Astellas Pharma US","keywords":"Medicine; Guideline; Fidaxomicin; Clostridioides; Intensive care medicine; Metronidazole; Vancomycin; Transplantation; Internal medicine; Randomized controlled trial; Hematopoietic stem cell transplantation; Population; Hematopoietic cell; Clostridium difficile; Antibiotics; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006480759,0.0001849891,0.0003664496,0.0002290968,0.00005296354,0.00001660423,0.00007758511,0.00009067465,0.0001517026],"category_scores_gemma":[0.00005417189,0.0001090646,0.00008412587,0.0006897404,0.000113724,0.00005459256,0.00003587985,0.0003095898,0.000007294038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007968191,"about_ca_system_score_gemma":0.00009964853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001195078,"about_ca_topic_score_gemma":0.00004768575,"domain_scores_codex":[0.9980136,0.00002731307,0.0008171367,0.0003986566,0.0004712819,0.0002720248],"domain_scores_gemma":[0.9988863,0.0004874477,0.00009772617,0.0002485439,0.0001737553,0.0001062142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006630829,0.002360888,0.8344836,0.01820502,0.0007621641,0.000209283,0.0006540061,0.0003936812,0.0004115667,0.0003543874,0.0312332,0.1043013],"study_design_scores_gemma":[0.02559265,0.004489816,0.9224021,0.005070283,0.005352026,0.00002623178,0.0002874372,0.005171045,0.006193822,0.0001989862,0.02462885,0.0005867622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871321,0.005964602,0.0007854038,0.00372994,0.0004878884,0.001467049,0.00008698824,0.00003381633,0.0003122675],"genre_scores_gemma":[0.9559887,0.04223218,0.000392042,0.0001570685,0.0003665399,0.0001840147,0.0001543707,0.00003369955,0.0004913844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1037146,"threshold_uncertainty_score":0.4447524,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02110359361786224,"score_gpt":0.3351017073786902,"score_spread":0.313998113760828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}